Impact Factor
3.20
Journal Citation Impact
Estimated influence, citation density, publishing volume, and citation integrity from the analytics table.
Citation rate
1.51
3,688 total citations
h5-index
62
h5 depth signal
Cited share
31.6%
808 of 2,553
Total citations
3,688
Citation footprint
Metric signal
1.68
External metric anchor
Self-citation
4.0%
147 self-citations
Citations Trend
Monthly Publications Cadence
Citing Geographic Demographics
United Kingdom
3,329
United States
2,359
Germany
974
France
729
China
605
Citing Fields of Research
Dermatology
6,873
Allergies
2,635
Musculoskeletal Disorders
1,330
Oncology
972
Epithelial Barriers
905
Publishing Activity & Reach
Volume, recency, access pattern, and citing-community signals from the journal analytics record.
All-time article footprint
40,935
Articles tracked across the journal lifetime
Indexed publication set
2,553
808 cited publications
Last 12 months
1,419
118.3 publications/month
Open access share
13.4%
190 OA publications in the last year
Leading citing country
United Kingdom
3,329 citing publications
Leading citing field
Dermatology
6,873 citing publications
Latest tracked publication
17 October 2026
10 recent records available
Coverage & Indexing History
v77n8,Aug.-Sept. 1965-
v77n8,Aug.-Sept. 1965-
Active Coverage
Active Coverage
Research Focus & Classification
Indexed Subjects
Dermatology
Allergies
Musculoskeletal Disorders
Auto-Inflammatory Disorders
Epithelial Barriers
Issuing & Sponsoring Bodies
Contributor
British Association of Dermatologists
Broad Categories
Dermatology
Allergies
Musculoskeletal Disorders
Epithelial Barriers
MeSH Descriptors
Dermatology
Syphilis
Latest Publications
Recent article records with DOI-first linking and condensed abstracts.
01
02
DOI 10.1093/bjd/ljag465
Open DOI
Beyond the Blister
Reflecting on the psychological burden of uncertainty and the unseen reality of living with pemphigus beyond the clinic room.
03
04
05
DOI 10.1093/bjd/ljag460
Open DOI
Summer Initiation of Ruxolitinib in Vitiligo: Natural Phototherapy Confounds the Seasonal Signal
This letter comments on the recent real-world study by Marzano et al. evaluating topical ruxolitinib in non-segmental vitiligo. We raise a methodological concern regarding the interpretation of the seasonal treatment initiation effect, a...
06
DOI 10.1093/bjd/ljag463
Open DOI
Skin Microbiome Metabolism in Cutaneous Microenvironments: Implications for Skin Health and Disease
The human skin surface harbors a complex ecosystem in which epidermal cells, resident microbiota, and surface metabolites cooperate to maintain a stable barrier against external stressors. Disruption of host or microbial metabolism at th...
07
DOI 10.1093/bjd/ljag457
Open DOI
Combination Therapy with Mogamulizumab and Pegylated Liposomal Doxorubicin in Tumoral Advanced-Stage Mycosis Fungoides/Sézary Syndrome: A Two-Case Report
Two patients with advanced-stage mycosis fungoides/Sézary syndrome achieved deep blood responses with mogamulizumab, including peripheral blood MRD negativity, but developed progressive tumoral skin disease. The addition of pegylated lip...
08
DOI 10.1093/bjd/ljag456
Open DOI
Comment on ‘Health-related quality of life in patients with basal cell naevus syndrome and high-frequency basal cell carcinoma: a questionnaire study’: reply from authors
Author’s response to “Comment on ‘Health-related quality of life in patients with basal cell naevus syndrome and high-frequency basal cell carcinoma: a questionnaire study’” by Rochmah et al.
09
DOI 10.1093/bjd/ljag455
Open DOI
Comment on ‘Health-related Quality of Life in Patients With Basal Cell Naevus Syndrome and High-frequency Basal Cell Carcinoma: a Questionnaire Study’
This letter highlights three considerations in interpreting the association between basal cell carcinoma burden and quality of life in basal cell naevus syndrome and high-frequency basal cell carcinoma. We discuss the distribution of les...
10
DOI 10.1093/bjd/ljag449
Open DOI
Distinct Gut Microbiota Signatures are Associated With Progression of Atherosclerosis in Patients With Psoriasis: Results From the EDSAP Study
Psoriasis patients have an increased risk of accelerated atherosclerosis. Our findings suggest that there are distinctive gut microbiota signatures in psoriasis patients that associate to atherosclerosis progression.
Bibliographical & Catalog Notes
Also issued online.
Official organ of the British Association of Dermatologists.
Vol. 124, no. 1 (JAN 1991)19910912 Notice published Printed on acid-free paper
-- ---A classified list of publications. Jan. 1964- London. v. Bound with main serial. W1 BR526 Suppl